In cancer, MYC is frequently expressed at high levels and in a constitutive way, as a result of either direct genomic rearrangements of the MYC locus or as a consequence of the aberrant activation of upstream oncogenic pathways, which support constitutive and robust transcriptional regulation of gene programs essential for tumor initiation and growth. Here, MYC is linked to cancer.